Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis

Area of Science:

• Nephrology
• Molecular Biology
• Cell Biology

Background:

• Src kinase activity is implicated in renal tumor pathogenesis and glomerular diseases.
• The specific role of Src kinase in renal interstitial fibrosis is not well understood.

Purpose of the Study:

• To investigate the role of Src kinase in renal interstitial fibroblast activation and extracellular matrix production.
• To evaluate the therapeutic potential of Src kinase inhibition in a murine model of renal interstitial fibrosis.

Main Methods:

• In vitro studies using cultured renal interstitial fibroblasts (NRK-49F) treated with a Src inhibitor (PP1) or Src-targeting siRNA.
• In vivo studies using a murine model of renal interstitial fibrosis induced by unilateral ureteral obstruction.
• Assessment of fibroblast activation markers (α-smooth muscle actin, fibronectin, collagen I), proliferation, and extracellular matrix deposition.
• Analysis of signaling pathways including TGF-β1, epidermal growth factor receptor, and STAT3.

Main Results:

• Src inhibition decreased the expression of α-smooth muscle actin, fibronectin, and collagen I in cultured fibroblasts.
• Src inhibition blocked renal fibroblast proliferation in vitro.
• Active Src (phospho-Src Tyr416) was upregulated in fibrotic kidneys in vivo.
• Src inactivation reduced renal fibroblast activation and extracellular matrix deposition in a murine fibrosis model.
• Src inhibition suppressed TGF-β1 signaling, EGFR, and STAT3 activation, and reduced G2/M cell cycle arrest.

Conclusions:

• Src kinase is a significant mediator of renal interstitial fibroblast activation and extracellular matrix accumulation.
• Targeting Src kinase demonstrates therapeutic potential for treating chronic renal interstitial fibrosis.